1.2.1.13	medicine	Onchocerca volvulus antigens possibly involved in protection against human onchocerciasis, GAPDH as a therapeutic target in helminth infections	672341	
1.2.1.13	medicine	results suggest that GAPDH may have a common role in modulating the pathophysiology of polyQ diseases like the Huntington desease	676851	
1.2.1.13	medicine	the results suggest that GAPDH is an active regulator in the phosphoinositide-mediated signaling pathway and a potential new target for insulin resistance treatment, diabetes, obesity and aging research	676125